Equity Research, Broker Reports, and media content on BIOCARTIS NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about BIOCARTIS NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on BIOCARTIS NV. We currently have 0 research reports from 0 professional analysts.

Open
10.3
Volume
0.0m
Range
10.2/10.4
Market Cap
459,875,511m
52 Week
6.60/12.5
Date Source Announcement
23Feb17 06:00 GNW Biocartis Group NV: Biocartis to host webcast for announcement 2016 financial results on 2 March 2017
22Dec16 06:01 GNW Biocartis Group NV: Biocartis and Amgen sign a RAS Biomarker Testing Collaboration in Europe
22Dec16 06:00 GNW Biocartis Group NV: Biocartis submits 510(k) file with US FDA for Idylla(TM) platform
15Dec16 06:00 GNW Biocartis Group NV: CE-marking Idylla(TM) NRAS-BRAF Mutation Test completes offering of metastatic colorectal cancer tests for clinical use on Idylla(TM) platform
14Dec16 06:00 GNW Biocartis Group NV: Disclosure of a transparency notification
12Dec16 06:00 GNW Biocartis Group NV: Disclosure of a transparency notification
07Dec16 06:00 GNW Biocartis Group NV: Biocartis launches second liquid biopsy assay - Assay co-developed with Merck for detection of KRAS mutations, operating directly on 1 ml blood plasma
  • Frequency of research reports

     

  • Research reports on

    BIOCARTIS NV

  • Providers covering

    BIOCARTIS NV